Free Trial

Envista (NVST) Competitors

$18.83
+0.19 (+1.02%)
(As of 10/4/2024 ET)

NVST vs. SOLV, PEN, BLCO, GKOS, INSP, STVN, TMDX, PRCT, AXNX, and LIVN

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Penumbra (PEN), Bausch + Lomb (BLCO), Glaukos (GKOS), Inspire Medical Systems (INSP), Stevanato Group (STVN), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Axonics (AXNX), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

Envista vs.

Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, media sentiment, risk, valuation and institutional ownership.

Solventum has a net margin of 0.00% compared to Envista's net margin of -52.25%. Envista's return on equity of 4.86% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
SolventumN/A N/A N/A
Envista -52.25%4.86%3.00%

In the previous week, Solventum had 7 more articles in the media than Envista. MarketBeat recorded 10 mentions for Solventum and 3 mentions for Envista. Envista's average media sentiment score of 1.26 beat Solventum's score of 1.14 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum has higher revenue and earnings than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.25B1.42N/AN/AN/A
Envista$2.53B1.28-$100.20M-$0.72-26.15

Solventum presently has a consensus price target of $58.25, suggesting a potential downside of 14.01%. Envista has a consensus price target of $19.59, suggesting a potential upside of 4.04%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.88
Envista
3 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.00

Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 40.24% of users gave Envista an outperform vote while only 0.00% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
SolventumOutperform Votes
No Votes
Underperform Votes
13
100.00%
EnvistaOutperform Votes
33
40.24%
Underperform Votes
49
59.76%

Summary

Envista beats Solventum on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE Exchange
Market Cap$3.24B$4.30B$5.53B$19.35B
Dividend YieldN/A1.31%5.57%3.47%
P/E Ratio-26.1523.26106.4327.17
Price / Sales1.281.771,164.6318.69
Price / Cash7.4913.2540.5220.75
Price / Book0.771.244.935.19
Net Income-$100.20M-$33.08M$116.97M$980.22M
7 Day Performance-4.71%-1.84%3.06%0.25%
1 Month Performance7.91%5.76%17.95%7.90%
1 Year Performance-28.59%5.87%24.11%25.86%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.7563 of 5 stars
$18.83
+1.0%
$19.59
+4.0%
-26.6%$3.24B$2.53B-26.1512,800Positive News
Gap Up
SOLV
Solventum
1.7403 of 5 stars
$67.40
+0.2%
$58.25
-13.6%
N/A$11.64B$8.25B0.0022,000Positive News
PEN
Penumbra
4.2803 of 5 stars
$194.34
-0.3%
$208.00
+7.0%
-12.5%$7.55B$1.06B82.004,200Insider Selling
BLCO
Bausch + Lomb
3.2342 of 5 stars
$18.92
+0.2%
$19.45
+2.8%
+10.9%$6.66B$4.50B-19.7113,300Analyst Forecast
GKOS
Glaukos
3.8082 of 5 stars
$131.37
+3.6%
$129.82
-1.2%
+87.1%$6.62B$341.73M-45.61780Positive News
INSP
Inspire Medical Systems
4.6913 of 5 stars
$209.99
+2.4%
$216.62
+3.2%
+21.4%$6.24B$705.71M-381.801,011
STVN
Stevanato Group
2.6338 of 5 stars
€19.15
-2.6%
N/A-39.3%$5.66B$1.09B34.825,635Gap Up
TMDX
TransMedics Group
4.2655 of 5 stars
$138.96
-3.4%
$174.30
+25.4%
+172.3%$4.58B$358.76M-408.71210Insider Selling
News Coverage
PRCT
PROCEPT BioRobotics
1.9765 of 5 stars
$73.23
-1.5%
$78.17
+6.7%
+143.0%$3.77B$176.58M-34.54430
AXNX
Axonics
3.3106 of 5 stars
$69.63
flat
$69.57
-0.1%
+23.7%$3.55B$408.81M-217.59610Insider Selling
Positive News
LIVN
LivaNova
4.3326 of 5 stars
$54.00
+1.5%
$70.80
+31.1%
+4.1%$2.92B$1.21B-90.002,900Analyst Forecast
Positive News

Related Companies and Tools


This page (NYSE:NVST) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners